Recent data indicates that retatrutide, a dual-action medication, might represent a major step in body reduction . This drug combines the actions of a GLP-1 analog and a GIP analog, possibly offering a enhanced outcome than current approaches . Study research have revealed encouraging findings , including substantial decreases in weight and improve